Curtis Rambaran is a Vice President of Clinical Sciences at Silence Therapeutics plc. He completed his Bachelor of Medicine and Bachelor of Surgeons in Medicine at the University of the West Indies, St. Augustine Campus. He is specialized in the Cardiovascular and Anti-inflammatory Drug Development, Translational Medicine, and Clinical Pharmacology